SSTR5 antagonist 2 TFA
SSTR5 Antagonist 1 (compound 10) is a highly potent, oral active and selective somatostatin (receptor) subtype 5 (SSTR5) antagonist and has potential for the research of treat type 2 diabetes mellitus (T2DM).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1254733-98-6
- Formule: C34H36F4N2O7
- Masse moléculaire:660.65
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
SSTR5[1].
SSTR5 antagonist 2 increases pancreatic insulin secretion as well as total and active GLP1 release, and demonstrates synergistic effects in combination with DPP4 inhibitors[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Rodent diabetic model without risk of hypoglycemia[1].
-
Dosage:10 mg/kg.
-
Administration:Orally.
-
Result:Increased both total and active circulating incretin hormone GLP1 levels.
Chemical Information
-
CAS No. 1254733-98-6
-
Masse moléculaire 660.65
-
Formule C34H36F4N2O7
-
SMILES
FC(C=C1)=CC=C1C2=C(OCC)C=C(CN3CCC4(CN(C5=CC=C(C(O)=O)C=C5)C(C4)=O)CC3)C=C2OCC.OC(C(F)(F)F)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)